A novel mutation within the extracellular domain of TrkA causes constitutive receptor activation

Oncogene. 2001 Mar 8;20(10):1229-34. doi: 10.1038/sj.onc.1204215.

Abstract

The TrkA NGF receptor extracellular region contains three leucine repeats flanked by cysteine clusters and two immunoglobulin-like domains that are required for specific ligand binding. Deletion of the immunoglobulin-like domains abolishes NGF binding and causes ligand independent activation of the receptor. Here we report a specific mutation that increases the binding affinity of the TrkA receptor for NGF. A change of proline 203 to alanine (P203A) in the linker region between the leucine repeats and the first Ig-like domain increased NGF binding by decreasing the ligand rate of dissociation. This mutated receptor was appropriately expressed on the cell surface and promoted ligand-independent neurite outgrowth in PC12nnr5 cells. The mutant receptor was capable of spontaneous dimerization and was constitutively phosphorylated in the absence of ligand. Moreover, expression of TrkA-P203A receptor in fibroblasts induced DNA synthesis and transformation and generated tumours in nude mice. These data suggest that domains outside of the immunoglobulin-like structure contribute to ligand binding and constitutive activation of Trk receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Binding Sites
  • Colony-Forming Units Assay
  • Ligands
  • Mutagenesis, Site-Directed
  • Mutation*
  • Nerve Growth Factor / metabolism*
  • Neurites / physiology
  • PC12 Cells / metabolism
  • Phosphorylation
  • Protein Binding
  • Protein Structure, Tertiary / genetics
  • Rats
  • Receptor, trkA / genetics*
  • Receptor, trkA / metabolism*
  • Structure-Activity Relationship

Substances

  • Ligands
  • Nerve Growth Factor
  • Receptor, trkA